Prophylaxis of post-ERCP pancreatitis: a practice survey

Gastrointestinal Endoscopy

Volumn 71, Issue 6, 2010, Pages

  Dumonceau, Jean Marc ^a   Rigaux, Johanne ^a   Kahaleh, Michel ^a   Gomez, Carlos Macias ^a   Vandermeeren, Alain ^a   Devière, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BELGIUM; COMMUNITY HOSPITAL; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EVIDENCE BASED MEDICINE; FRANCE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INCIDENCE; ITALY; ODDI SPHINCTER; PANCREAS STENTING; PANCREAS SURGERY; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; SPAIN; SURGICAL TECHNIQUE; VATER PAPILLA; WORK EXPERIENCE;

EID: 77951637928     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.10.055     Document Type: Article

References (33)

1. Masci E., Mariani A., Curioni S., et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35 (2003) 830-834
2. Williams E.J., Taylor S., Fairclough P., et al. Risk factors for complication following ERCP: results of a large-scale, prospective multicenter study. Endoscopy 39 (2007) 793-801
3. Cotton P.B., Garrow D.A., Gallagher J., et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 70 (2009) 80-88
4. Mazen Jamal M., Yoon E.J., Saadi A., et al. Trends in the utilization of endoscopic retrograde cholangiopancreatography (ERCP) in the United States. Am J Gastroenterol 102 (2007) 966-975
5. Andriulli A., Loperfido S., Napolitano G., et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 102 (2007) 1781-1788
6. Dai H.F., Wang X.W., and Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int 8 (2009) 11-16
7. Elmunzer B.J., Waljee A.K., Elta G.H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 57 (2008) 1262-1267
8. Zheng M., Xia H.H., and Chen Y. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut 57 (2008) 1632-1633
9. Andriulli A., Forlano R., Napolitano G., et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 75 (2007) 156-163
10. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. a meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
11. Das A., Singh P., Sivak M.V., et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 65 (2007) 960-968
12. Brackbill S., Young S., Schoenfeld P., et al. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 64 (2006) 45-52
13. Chahal P., Tarnasky P.R., Petersen B.T., et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 7 (2009) 834-839
14. Elta G.H. Temporary prophylactic pancreatic stents: which patients need them?. Gastrointest Endosc 67 (2008) 262-264
15. Janssens F., Deviere J., Eisendrath P., et al. Carbon dioxide for gut distension during digestive endoscopy: technique and practice survey. World J Gastroenterol 15 (2009) 1475-1479
16. Varadarajulu S., Kilgore M.L., Wilcox C.M., et al. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 64 (2006) 338-347
17. Johanson J.F., Cooper G., Eisen G.M., et al. Quality assessment of ERCP. Endoscopic retrograde cholangiopacreatography. Gastrointest Endosc 56 (2002) 165-169
18. Williams E.J., and BSG Audit of ERCP Steering Committee. Defining the difficult ERCP. Performance of the ASGE (modified Schutz) scoring system in a prospectively studied cohort of 5264 procedures. [abstract]. Gastrointest Endosc 63 (2009) AB87
19. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59 (2004) 8-14
20. Baillie J., and Testoni P.A. Are we meeting the standards set for ERCP?. Gut 56 (2007) 744-746
21. Williams E.J., Taylor S., Fairclough P., et al. Are we meeting the standards set for endoscopy?. Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatography practice. Gut 56 (2007) 821-829
22. Lieb J.G., and Draganov P.V. Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography. World J Gastroenterol 13 (2007) 3567-3574
23. Verma D., Kapadia A., and Adler D.G. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc 66 (2007) 283-290
24. Sofuni A., Maguchi H., Itoi T., et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 5 (2007) 1339-1346
25. Dumonceau J.M., Devière J., and Cremer M. A new method of achieving deep cannulation of the common bile duct during endoscopic retrograde cholangiopancreatography. Endoscopy 30 (1998) S80
26. Cennamo V., Fuccio L., Zagari R.M., et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?. a meta-analysis of randomized controlled trials. Am J Gastroenterol 104 (2009) 2343-2350
27. Cheung J., Tsoi K.K., Quan W.-L., et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc 70 (2009) 1211-1219
28. Devière J. Using the pancreas for common bile duct cannulation?. Endoscopy 35 (2003) 750-751
29. Ito K., Fujita N., Noda Y., et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic guidewire placement for achieving selective biliary cannulation?. a prospective randomized controlled trial. [abstract]. http://www.uegf.org/publications/abstracts2008/abstract_detail.php?aId=O P082&navId=218 Accessed October 3, 2009
30. Fehmi S.M.A., Schoenfeld P.S., Scheiman J.M., et al. 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents. [abstract]. Gastrointest Endosc 67 (2008) AB328-AB329
31. Rashdan A., Fogel E.L., McHenry L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329
32. Disario J.A. Hospital volume and ERCP outcomes: the writing is on the wall. Gastrointest Endosc 64 (2006) 348-350
33. Werner R.M., and McNutt R. A new strategy to improve quality: rewarding actions rather than measures. JAMA 301 (2009) 1375-1377